1. Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis.
   Chia-Yang Li, 0 CrossRef
2. NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target
   Hongbo Huang et al, 2022, International Journal of Genomics CrossRef
3. DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung Adenocarcinoma
   Yang Zhao et al, 2022, Front. Mol. Biosci. CrossRef
4. Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma
   Yin-wei Dai et al, 2022, Front. Oncol. CrossRef
5. Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
   Mahshid Deldar Abad Paskeh et al, 2023, Pharmacol Res CrossRef
6. Biological Functions of the DNA Glycosylase NEIL3 and Its Role in Disease Progression Including Cancer
   Lang Chen et al, 2022, Cancers CrossRef
7. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3
   Tao Wang et al, 2023, Pulmonary Pharmacology & Therapeutics CrossRef
8. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation
   Mengzhao Zhang et al, 2023, DNA Repair CrossRef
9. Hypoxia increases the biogenesis of IGF2BP3-bound circular RNAs
   Kriti Kaushik et al, 2024, Mol Biol Rep CrossRef
10. Exploring the potential of drug repurposing for liver diseases: A comprehensive study
    Fares E.M. Ali et al, 2024, Life Sciences CrossRef
11. Enhancing Cisplatin Drug Sensitivity through PARP3 Inhibition: The Influence on PDGF and G-Coupled Signal Pathways in Cancer
    Ayşegül Varol et al, 2024, Chemico-Biological Interactions CrossRef